✦ LIBER ✦

Clinical course in Parkinson's disease with elevated homocysteine

✍ Scribed by Padraig E. O'Suilleabhain; Robert Oberle; Cristina Bartis; Richard B. Dewey Jr; Teodoro Bottiglieri; Ramon Diaz-Arrastia

Book ID: 116820132
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 325 KB
Volume: 12
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2005.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical course of patients with idiopat

Clinical course of patients with idiopathic Parkinson's disease

✍ Dr. R. A. C. Roos; J. C. F. Jongen; E. A. Van Der Velde 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

## Abstract We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a s

Elevation of total homocysteine levels i

Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel

✍ Thomas Müller; Constanze Jugel; Reinhard Ehret; Georg Ebersbach; Gunar Bengel; S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 253 KB

Serum homocysteine and physical exercise

Serum homocysteine and physical exercise in patients with Parkinson's disease

✍ Carla Manuela Crispim NASCIMENTO; Florindo STELLA; Célia Regina GARLIPP; Ruth Fe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

Homocysteine levels after acute levodopa

Homocysteine levels after acute levodopa intake in patients with Parkinson's disease

✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract Levodopa (L‐dopa) administered with a dopadecarboxylase inhibitor (DDI) increases homocysteine plasma levels. This may support the onset of atherosclerosis‐related disorders and neuropsychiatric complications in patients with Parkinson's disease (PD). This homocysteine elevation is cons

Amphetamine exposure is elevated in Park

Amphetamine exposure is elevated in Parkinson's disease

✍ Elisabeth R. Garwood; Wosen Bekele; Charles E. McCulloch; Chadwick W. Christine 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Cysteine elevation in levodopa-treated p

Cysteine elevation in levodopa-treated patients with Parkinson's disease

✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei